Search

Author/Creator Mullen, Jamie

1. Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics. Issue 3 (10th January 2018)

Authors:
Ye, Naidong; Monk, Scott A.; Daga, Pankaj; Bender, David M.; Rosen, Laura B.; Mullen, Jamie; Minkwitz, Margaret C.; Kugler, Alan R.
Journal:
Clinical pharmacology in drug development
Issue:
Volume 7:Issue 3(2018)
Page Start:
233
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P‐gp Substrate. (18th December 2019)

Authors:
Monk, Scott A.; Kugler, Alan R.; Andersen, Scott W.; Ayan‐Oshodi, Mosun A.; James, Douglas E.; Mullen, Jamie; Zimmer, Jennifer A.; Willis, Brian A.
Journal:
Journal of clinical pharmacology
Issue:
Volume 60:Number 5(2020)
Page Start:
586
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. DT‐01‐04: LANABECESTAT: BASELINE CHARACTERISTICS OF PARTICIPANTS RANDOMIZED IN THE PHASE 2/3 AMARANTH STUDY. (1st July 2006)

Authors:
Sims, John R.; Downing, AnnCatherine M.; Andersen, Scott W.; Wessels, Alette M.; Zimmer, Jennifer A.; Mullen, Jamie; Schumi, Jennifer; Stern, Robert A.; Vellas, Bruno; Boada, Mercè; Cohen, Sharon; MacSweeney, Emer; Tariot, Pierre N.
Journal:
Alzheimer's & dementia
Issue:
Volume 14:Supplement 7(2018)Part 31
Page Start:
P1666
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. FTS3‐01‐03: PERFORMANCE ON EXPLORATORY EFFICACY VARIABLES IN AMARANTH, A RANDOMIZED PHASE 2/3 STUDY IN EARLY ALZHEIMER'S DISEASE WITH LANABECESTAT. (1st July 2019)

Authors:
Stern, Robert A.; Wessels, Alette M.; Selzler, Katherine J.; Andersen, Scott W.; Mullen, Jamie; Sims, John R.
Journal:
Alzheimer's & dementia
Issue:
Volume 15:Supplement 7S(2019)Part 17
Page Start:
P873
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease. Issue 1 (14th February 2021)

Authors:
Zimmer, Jennifer A.; Shcherbinin, Sergey; Devous, Michael D.; Bragg, Sonja M.; Selzler, Katherine J.; Wessels, Alette M.; Shering, Craig; Mullen, Jamie; Landry, John; Andersen, Scott W.; Downing, AnnCatherine M.; Fleisher, Adam S.; Svaldi, Diana Otero; Sims, John R.
Journal:
Alzheimer's & dementia
Issue:
Volume 7:Issue 1(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗